Clinical Trials
26 trialsNCT06937177 2026-05-11
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy
Endevica Bio
Phase 2 Recruiting
NCT07565415 2026-05-04
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy
Nanfang Hospital, Southern Medical University
Phase 2 Not yet recruiting
NCT07533227 2026-04-16
FMT-CACH
Changzhou No.2 People's Hospital
Phase 2 Not yet recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT04844970 2025-11-17
Anamorelin Study for Advanced Pancreatic Cancer
Lahey Clinic
Phase 2 Terminated
NCT07168226 2025-09-11
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
MetaFines
Phase 2 Not yet recruiting
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT03245658 2023-12-18
The Effect of Cannabis in Pancreatic Cancer
University of Copenhagen
Phase 2 Withdrawn
NCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT05380479 2022-05-18
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Unknown
NCT04907864 2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2 Unknown
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT01505764 2018-07-17
The Role of Ghrelin in Cancer Cachexia
VA Office of Research and Development
Phase 2 Terminated
NCT02416570 2016-09-16
Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?
University of Nottingham
Phase 2 Terminated
NCT00558558 2016-05-13
Haelan and Nutrition in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01433263 2016-03-02
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
Novartis
Phase 2 Completed
NCT02350855 2015-01-30
Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients
University of Westminster
Phase 2 Completed
NCT01238107 2014-09-10
A Clinical Study With MT-102 in Subjects With Cancer Cachexia
Akamis Bio
Phase 2 Completed
NCT00467844 2014-07-11
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
GTx
Phase 2 Completed
NCT00066248 2014-02-03
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
University of South Florida
Phase 2 Completed
NCT00219817 2013-09-02
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00527319 2013-01-30
VT-122
Vicus Therapeutics
Phase 2 Completed
NCT00004912 2012-05-30
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
Northwestern University
Phase 2 Completed
NCT00895726 2012-01-13
Pilot Study of APD209 in Cancer Cachexia
Acacia Pharma Ltd
Phase 2 Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed
NCT00535015 2008-07-22
Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
Anaborex
Phase 2 Terminated